Visicu Inc (EICU)

HEALTH CARE: HEALTH CARE SERVICES
SIC: SERVICES-PREPACKAGED SOFTWARE
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

217 EAST REDWOOD STREET BALTIMORE, MD 21202-3315

Visicu, Inc. was founded in March 1998 by two Johns Hopkins Hospital intensivists determined to improve patient care in the ICU. It is a healthcare information technology and clinical solutions company focused on transforming the delivery of hospital-based critical care through its eICU Program. Its eICU Program is an advanced remote monitoring system for ICUs that allows hospitals to help improve patient treatment outcomes by leveraging their scarce critical care trained staff to monitor ICU patients more frequently and to intervene earlier to prevent or manage crises. eICU Program consists of an eICU Center with direct data, video and audio links with ICU patient rooms and its eCareManager suite of software products. In the eICU Center, intensivists and critical care nurses use multiple screens at eCareManager workstations to monitor real-time data, current visual status, care plan, diagnostic results and treatment history for each patient. Visicu focuses on delivering effective implementation, user training and workflow redesign and ongoing support services as an integral part of its eICU Program. The Company sells its eICU Program primarily to multi-hospital systems and networks of community and rural hospitals. It uses a direct sales model. The Company's sales representatives have experience in healthcare related direct sales and are trained in the eICU Program and the needs of its potential customers. Visicu's sales strategy includes identifying potential customers in various regions and then qualifying a subgroup in each region that will then become the focus of the sales effort. Marketing strategy is designed to generate qualified sales leads and build awareness of the eICU Program as a more effective alternative to the traditional management of ICUs. Visicu sells its eICU Program primarily to multi-hospital systems. The Company's Customer Support department is designed to ensure that its systems are fully operational and that any customer problems are quickly resolved. It provides 24-hour per day, 365-day per year service and support for the software. eCareManager suite of software products operate on its customers' networks. Visicu follows a formal product development process based on a two-year product development plan and employ dedicated product development personnel. The Company is actively developing additional products and applications for its products designed to better serve the customers and expand its revenue opportunities. It focuses its new release efforts on five areas: architecture; usability; new functions; integration; and support/installation. Visicu relies on a combination of trade secrets, copyrights, trademarks, patents and patent applications, licenses and employee and third-party nondisclosure agreements and other protective measures to protect its proprietary technology and brand. Its trademarks include VISICU(r), eICU(r), eVantage(r), SmartAlerts(r), eCareMobiletm, eCareManagertm, eLerttm and its logo. The Company markets, sells, and distributes its products and services in the heavily regulated U.S. healthcare industry. As of December 31, 2005, Visicu had 94 employees.

View SEC Filings from EICU instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding EICU (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding EICU BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ALTMAN STUART H

  • Director
No longer subject to file 2008-02-20 0

CARDINAL HEALTH PARTNERS LP

  • 10% Owner
No longer subject to file 2008-02-20 0

SAMPLE FRANK T CHAIRMAN AND CEO

  • Officer
  • Director
No longer subject to file 2008-02-20 0

STERLING VENTURE PARTNERS L P

  • 10% Owner
No longer subject to file 2008-02-20 0

JOHNSON VAN R

  • Director
No longer subject to file 2008-02-20 0

KEENAN FRANCES M

  • Director
No longer subject to file 2008-02-20 0

ESTRADA VINCENT E SR VP AND CFO

  • Officer
No longer subject to file 2008-02-20 0

CLARKE JOHN K

  • Director
  • 10% Owner
No longer subject to file 2008-02-20 0

BRESLOW MICHAEL J EVP CLINICAL R&D

  • Officer
No longer subject to file 2008-02-20 0

BRONFEIN MICHAEL G

  • Director
  • 10% Owner
No longer subject to file 2008-02-20 0

ROSENFELD BRIAN A EVP AND CMO

  • Officer
  • Director
No longer subject to file 2008-02-20 0

PARTECH U.S. PARTNERS IV, L.L.C.

  • Director
  • 10% Owner
No longer subject to file 2008-02-20 0

SABIN RALPH C

  • Director
  • 10% Owner
No longer subject to file 2008-02-20 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments